Healthcare

While many biotech companies are scrounging for funds, Clinuvel face...

While many biotech companies are scrounging for funds, Clinuvel faces criticism for having an excess of cash, according to Biocurious.

Orthocell Secures FDA Approval for Remplir, Unveiling US Market Pote...

Highlights,FDA grants clearance to Orthocell (OCC) for nerve repair product Remplir.,Entry into the US market poised to boost Orthocell's revenue pros...

Race Oncology initiates Australian site for Phase I solid tumour tri...

Highlights:,Race Oncology Ltd establishes an Australian clinical site for its Phase 1 trial.,The study focuses on testing RC220 in combination with ch...

Innovative Cancer Treatment Progress: Race Oncology (ASX:RAC) Advanc...

Highlights,Race Oncology is advancing a safer chemotherapy alternative.,Clinical,trials to,explore reduced side effects and enhanced efficacy.,Potenti...

Race launches initial site for Phase I trial of a cardioprotective a...

Highlights,Southside Cancer Care Centre in Miranda has been established as the initial site for the Phase I trial of RC220.,The trial includes partici...

Compumedics Gains Traction in China with Brain Mapping Technology

Highlights,Compumedics announces a new deal with Hangzhou Normal University for its Orion LifeSpan MEG system.,The agreement adds to previous installa...

Artrya Limited Achieves Milestone with FDA Clearance for Groundbreak...

Highlights,Artrya Limited (AYA) secures FDA clearance for its Salix® Coronary Anatomy.,Strategic partnerships set to boost U.S. commercialization.,New...

Analyzing ResMed CDI’s (ASX:RMD) Financial and Market Performance

Highlights,ResMed CDI (RMD) navigates a market downturn with robust financial health.,Innovation and global presence sustain ResMed’s industry dominan...

Healius (ASX:HLS) Charts Future with Bold Pathology Strategy and Sub...

Highlights,Healius,(HLS) unveils a robust Pathology Strategy with,potential,high EBIT margins.,Announces special $300 million dividend following a str...

Should You Be Concerned About EBR Systems' (EBR) Debt Despite the La...

Should You Be Concerned About EBR Systems' (EBR) Debt Despite the Lack of Earnings?

Mesoblast begins Ryoncil sales in the US as shareholders remain eage...

Mesoblast begins Ryoncil sales in the US as shareholders remain eager for revenue.

Produced in Australia: ASX Companies Enhancing Domestic Health and M...

Highlights,Government initiatives and industry investments are strengthening domestic medical manufacturing.,Prominent companies like CSL, ResMed, and...

EMVision Launches Crucial Trial for Emu Brain Scanner to Diagnose St...

Highlights,EMVision Medical Devices (ASX:EMV) has commenced a pivotal validation trial for its EMU bedside brain scanner.,Trial sites include the Roya...

CleanSpace Holdings Limited's (ASX:CSX) Recent Stock Performance and...

Highlights,CleanSpace Holdings Limited (ASX:CSX) experienced a sharp rise in stock value.,Despite the jump, its P/S ratio remains low compared to indu...

Clinuvel Pharmaceuticals Announces Extended Share Repurchase Initiat...

Highlights,Clinuvel Pharmaceuticals (CUV) extends its share repurchase program for another year.,Plans to repurchase an additional 1.5 million shares,...

Healius (ASX:HLS) Surges After Announcing Lucrative Dividend Post-Su...

Highlights,Healius (ASX:HLS) shares surged 14.5% following a special dividend announcement.,The dividend is announced after the $300 million sale of L...

Neuren Pharmaceuticals Advances on Lifesaving Pediatric Treatment

Highlights,Neuren Pharmaceuticals progresses with a pivotal new treatment for infants.,Upcoming discussions with the FDA mark a significant step forwa...

The morning catch up: ASX on the green as small and mid cap companie...

Highlights:,ASX 200,records a steady performance amid sector shifts.,Healthcare Stocks,gain traction with new product launches.,Small and mid-cap comp...

Prescient Therapeutics opens first clinical site for Phase 2a PTX-10...

Highlights,Prescient Therapeutics Ltd (ASX,:PTX,, OTC,:PSTTF,),initiates a Phase 2a clinical trial for PTX-100 in cutaneous T-cell lymphoma.,The first...

Clinuvel's Stroke Drug Trial Reports Positive Findings

Highlights:,ASX 200, Healthcare Stocks,gain attention as Clinuvel (ASX:CUV) reports trial progress.,Stroke drug,PRENUMBRA,demonstrates a favorable saf...